Insider Trading (SEC Form 4)


Insiders are officers, directors, or significant investors. This page shows recent insider transactions for Pharmaceutical.

Transaction
Date
CompanyInsider Code
(see below)
Shares Post Shares Percent
Change
Share
Price
Tran
Value
Post
Value
Percent
Change
2017-11-20 BGNE Huang Jane (CMO, Hematology) S -1,000 266,000 -0.37 87 -87,000 23,142,000 -0.38
2017-11-20 PCRX Jones James B (SVP & Chief Medical Officer) S -850 16,823 -4.81 41.1088 -34,942 691,573 -5.05
2017-11-17 LGND LAMATTINA JOHN L ( Director) M 4,000 24,956 19.09 10.12 40,480
2017-11-17 CNCE Tung Roger D (Chief Executive Officer Director) M 7,340 773,841 0.96 4.58 33,617
2017-11-17 ABT Blaser Brian J (Executive Vice President) M 3,233 146,387 2.26 26.1879 84,665
2017-11-17 ABT Blaser Brian J (Executive Vice President) M 6,333 152,720 4.33 23.2280 147,103
2017-11-17 PCRX Williams Kristen Marie (CAO and General Counsel) M 7,857 29,169 36.87 25.37 199,332
2017-11-17 CNCE Tung Roger D (Chief Executive Officer Director) F -1,607 772,234 -0.21 20.91 -33,602
2017-11-17 LXRX Invus Public Equities, L.P. ( Director 10% Owner) Artal International S.C.A. ( Director 10% Owner) Artal International Management S.A. ( Director 10% Owner) Artal Group S.A. ( Director 10% Owner) Westend S.A. ( Director 10% Owner) Stichting Administratiekantoor Westend ( Director 10% Owner) Minne Pascal ( Director 10% Owner) Invus, L.P. ( Director 10% Owner) Invus Advisors, L.L.C. ( Director 10% Owner) Invus Public Equities Advisors, LLC ( Director 10% Owner) P 50,000 58,274,650 0.09 9.85 492,500 574,005,302 0.09
2017-11-17 FGEN Neff Thomas B (Chief Executive Officer Director) S -2,900 3,156,701 -0.09 46.98 -136,242 148,301,813 -0.09
2017-11-17 FGEN Neff Thomas B (Chief Executive Officer Director) S -16,000 3,159,601 -0.50 46.60 -745,600 147,237,407 -0.51
2017-11-17 CORI Broadfin Healthcare Master Fund Ltd ( 10% Owner) Broadfin Capital, LLC ( 10% Owner) KOTLER KEVIN ( 10% Owner) S -65,345 3,702,881 -1.73 11.01 -719,448 40,768,720 -1.76
2017-11-17 CORI Broadfin Healthcare Master Fund Ltd ( 10% Owner) Broadfin Capital, LLC ( 10% Owner) KOTLER KEVIN ( 10% Owner) S -100,000 3,602,881 -2.70 10.95 -1,095,000 39,451,547 -2.78
2017-11-17 CORI Broadfin Healthcare Master Fund Ltd ( 10% Owner) Broadfin Capital, LLC ( 10% Owner) KOTLER KEVIN ( 10% Owner) S -9,255 3,593,626 -0.26 10.96 -101,435 39,386,141 -0.26
2017-11-17 CORI Broadfin Healthcare Master Fund Ltd ( 10% Owner) Broadfin Capital, LLC ( 10% Owner) KOTLER KEVIN ( 10% Owner) S -25,000 3,568,626 -0.70 10.95 -273,750 39,076,455 -0.70
2017-11-17 LGND Aryeh Jason ( Director) S -24,400 154,901 -13.61 140.22 -3,421,368 21,720,218 -15.75
2017-11-17 LGND HIGGINS JOHN L (Chief Executive Officer Director) S -2,258 141,284 -1.57 140.34 -316,888 19,827,797 -1.60
2017-11-17 FGEN Neff Thomas B (Chief Executive Officer Director) S -418 210,132 -0.20 46.75 -19,542 9,823,671 -0.20
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -2,700 150,020 -1.77 55.5750 -150,052 8,337,362 -1.80
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -1,000 149,020 -0.67 55.5710 -55,571 8,281,190 -0.67
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -3,944 145,076 -2.65 55.5700 -219,168 8,061,873 -2.72
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -1,922 143,154 -1.32 55.5650 -106,796 7,954,352 -1.34
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -2,000 141,154 -1.40 55.53 -111,060 7,838,282 -1.42
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -900 140,254 -0.64 55.5301 -49,977 7,788,319 -0.64
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -713 139,541 -0.51 55.531 -39,594 7,748,851 -0.51
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -200 139,341 -0.14 55.532 -11,106 7,737,884 -0.14
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -200 139,141 -0.14 55.5321 -11,106 7,726,792 -0.14
2017-11-17 ABT Blaser Brian J (Executive Vice President) S -10,287 128,854 -7.39 55.535 -571,289 7,155,907 -7.98
2017-11-17 LGND LAMATTINA JOHN L ( Director) S -4,000 20,956 -16.03 139.79 -559,160 2,929,439 -19.09
2017-11-17 LGND Korenberg Matthew E (VP, Finance and CFO) S -6,559 8,147 -44.60 142.63 -935,510 1,162,007 -80.51
2017-11-17 FGEN Kurkijarvi Kalevi ( Director) S -2,000 24,000 -7.69 46.65 -93,300 1,119,600 -8.33
2017-11-17 PCRX Williams Kristen Marie (CAO and General Counsel) S -7,857 21,312 -26.94 40.00 -314,280 852,480 -36.87
2017-11-17 ADRO Templeman Blaine (Executive VP, General Counsel) S -243 58,834 -0.41 8.85 -2,151 520,681 -0.41
2017-11-16 MRTX venBio Select Advisor LLC ( 10% Owner) Aghazadeh Behzad ( 10% Owner) X 37,500 4,398,101 0.86 7.86 294,750
2017-11-16 UTHR MAHON PAUL A (EVP & General Counsel) M 6,000 41,426 16.94 57.15 342,900
2017-11-16 CPRX O'Keeffe Charles B ( Director) M 50,000 513,376 10.79 0.47 23,500
2017-11-16 UTHR ROTHBLATT MARTINE A (Chairman & CEO Director) M 1,261 1,401 900.71 30.75 38,776
2017-11-16 UTHR ROTHBLATT MARTINE A (Chairman & CEO Director) M 915 681,630 0.13 30.75 28,136
2017-11-16 UTHR ROTHBLATT MARTINE A (Chairman & CEO Director) M 5,800 7,201 413.99 53.42 309,836
2017-11-16 IONS HOUGEN ELIZABETH L (SVP, Finance & CFO) M 7,000 17,392 67.36 10.29 72,030
2017-11-16 IONS KLEIN JOSEPH III ( Director) M 2,812 10,039 38.91 12.94 36,387
2017-11-16 MRTX Christensen Jamie (SVP, Chief Science Officer) M 10,000 12,670 374.53 8.50 85,000
2017-11-16 AMPH Shohet Stephen B. ( Director) M 7,862 31,978 32.60 10.77 84,674
2017-11-16 PCRX Williams Kristen Marie (CAO and General Counsel) M 2,143 23,455 10.06 25.37 54,368
2017-11-16 CORT MAHONEY DAVID L ( Director) G -15,785 1,119,888 -1.39
2017-11-16 UTHR MAHON PAUL A (EVP & General Counsel) D -6,000 35,426 -14.48 121.62 -729,720
2017-11-16 NKTR Nicholson John (SVP & Chief Operating Officer) D -6,620 246,536 -2.61 44.23 -292,803
2017-11-16 NKTR Labrucherie Gil M (SVP & Chief Financial Officer) D -6,698 76,716 -8.03 44.23 -296,253
2017-11-16 NKTR Hora Maninder (SVP Pharma Dev & Mfg Ops) D -5,597 67,636 -7.64 44.23 -247,555
2017-11-16 NKTR Gergel Ivan P. (SVP & Chief Medical Officer) D -5,022 56,553 -8.16 44.23 -222,123
A
Grant, award, or other acquisition of securities from the company (such as an option)
K
Equity swaps and similar hedging transactions
P
Purchase of securities on an exchange or from another person
S
Sale of securities on an exchange or to another person
D
Sale or transfer of securities back to the company
F
Payment of exercise price or tax liability using portion of securities received from the company
M
Exercise or conversion of derivative security received from the company (such as an option)
G
Gift of securities by or to the insider
V
A transaction voluntarily reported on Form 4
J
Other (accompanied by a footnote describing the transaction)